HPGC Renmintongtai Pharmaceutical (SHSE:600829) Other Operating Expense : ¥103 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical Other Operating Expense?

HPGC Renmintongtai Pharmaceutical's Other Operating Expense for the three months ended in Mar. 2024 was ¥8 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥103 Mil.

HPGC Renmintongtai Pharmaceutical's quarterly Other Operating Expense increased from Sep. 2023 (¥-31 Mil) to Dec. 2023 (¥86 Mil) but then declined from Dec. 2023 (¥86 Mil) to Mar. 2024 (¥8 Mil).

HPGC Renmintongtai Pharmaceutical's annual Other Operating Expense declined from Dec. 2021 (¥109 Mil) to Dec. 2022 (¥106 Mil) and declined from Dec. 2022 (¥106 Mil) to Dec. 2023 (¥100 Mil).

HPGC Renmintongtai Pharmaceutical Other Operating Expense Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical Other Operating Expense Chart

HPGC Renmintongtai Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

218.11

134.04

108.54

106.39

100.06

HPGC Renmintongtai Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															4.52	40.68	-30.66	85.53	7.59

HPGC Renmintongtai Pharmaceutical Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥103 Mil.

HPGC Renmintongtai Pharmaceutical Other Operating Expense Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076

Website

http://www.sanjing.com.cn

HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.

Executives

Yue Xian Zhi	senior management
Zhang Li Jun	Director

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Headlines

No Headlines